Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors
Subject: Heart Disease - PUBLISHED VIA BMJ Publishing Group Limited
View Source >>
C Y Hepburn, S K Walsh, C L Wainwright
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Published via Author Manuscript
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Published via American Journal of Physiology
Published via British Pharmacological Society
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Published via British Journal of Pharmacology
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
Published via Journal of Cardiovascular Pharmacology and Therapeutics